Net Revenue. As used in this Warrant Agreement, the term "Net Revenue" shall mean the total ticket revenue received by the Company from tickets sold for travel on the Warrant Holder and its Code Share Partners, net of federal excise and segment taxes, passenger facility charges and related fees. The parties acknowledge that credit card processing fees, and any processing fees or similar fees charged by the Company to the consumer in connection with the sale of a ticket shall not be included in the calculation of Net Revenue. Attached hereto as Exhibit D is an example of the calculation of Net Revenue.
Net Revenue. Section 5.11 shall be deleted in its entirety and replaced with the following in lieu thereof:
Net Revenue. Maintain at all times, to be tested as of the last day of each calendar quarter, aggregate Net Revenue, as determined in accordance with GAAP:
Net Revenue gross revenue of Animas Group on a consolidated basis (excluding all revenue from Sub-licensees) from the sale of Debiotech Micro-Needle Products to distributors and end-users minus contractual allowances and discounts, as calculated in accordance with US Generally Accepted Accounting Principles, as such principles are in effect at that time, and as recognized in accordance with Animas’ standard accounting practices in effect for the relevant period, consistently applied ( “GAAP”).
Net Revenue. “Net Revenue” means the total revenue for season passes, gate sales, and all rentals, less applicable sales tax. Net Revenue shall not include concessions sales.
Net Revenue. Net Revenue" means the amount collected by ----------- SPRT for SPRT's sale of licenses to the Product Extension to Referred Customers, less (a) 10% for sales expenses, and (b) any associated freight charges, insurance and other costs of shipping and handling, taxes and duties.
Net Revenue. For a given period, Gross Revenue less Excepted Expenses.
Net Revenue. All revenue received in connection with Licensed Products created by or on behalf of Licensee or its sublicensees less: (a) Chargebacks (as defined below) incurred by Licensee; (b) freight, taxes, insurance, duties, customs and brokerage fees incurred by Licensee; and (c) in the case of sublicenseing, agency fees, IP registration and protection and enforcement costs. “Chargebacks” are defined as price protections, returns, co-op, MDF and other customary deductions and discounts, taken or granted by Licensee to its customers specifically in connection with Licensed Products created by or on behalf of Licensee or its sublicensees, plus, except with respect to sublicensing revenue, an additional three percent (3%) of gross receipts deducted in order to reflect retailer-level deductions taken for early payment, volume discounts, and similar items, but excluding marketing expenses.
Net Revenue. AtheroGenics shall pay Emory the following running royalties on Net Revenue:
Net Revenue. Consolidated net revenue of at least (i) $3,000,000 for the fiscal quarter ending September 30, 2005, (ii) $3,500,000 for the fiscal quarter ending December 31, 2005, (iii) $4,000,000 for the fiscal quarter ending March 31, 2006, (iv) $4,750,000 for the fiscal quarter ending June 30, 2006, (v) $5,250,000 for the fiscal quarter ending September 30, 2006, (vi) $6,000,000 for the fiscal quarter ending December 31, 2006, and (vii) the greater of (A) $6,250,000, and (B) eighty percent (80.0%) of Borrower's Board-approved operating plan, for the fiscal quarter ending March 31, 2007 and as of the last day of each fiscal quarter thereafter.
